{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:23:34Z","timestamp":1775121814286,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[1993,7,1]],"date-time":"1993-07-01T00:00:00Z","timestamp":741484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefe's Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[1993,7]]},"DOI":"10.1007\/bf00919645","type":"journal-article","created":{"date-parts":[[2005,1,12]],"date-time":"2005-01-12T06:04:41Z","timestamp":1105509881000},"page":"384-388","source":"Crossref","is-referenced-by-count":20,"title":["Two topical carbonic anhydrase inhibitors sezolamide and dorzolamide in Gelrite vehicle: A multiple-dose efficacy study"],"prefix":"10.1007","volume":"231","author":[{"given":"F. P.","family":"Gunning","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. L.","family":"Greve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Bron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Bosc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. G.","family":"Royer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L.","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Lesure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Sirbat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"491","volume":"12","author":"MF Armaly","year":"1973","unstructured":"Armaly MF, Rao KR (1973) The effect of pilocarpine Ocusert with different release rates on intraocular pressure. Invest Ophthalmol 12:491","journal-title":"Invest Ophthalmol"},{"key":"CR2","first-page":"374","volume":"30","author":"JJ Baldwin","year":"1989","unstructured":"Baldwin JJ, Ponticello GS, Murcko M, et al (1989) Three-dimensional structure of the carbonic anhydrase inhibitor complex derived from human carbonic anhydrase II and the optical isomers of Mk-927. Invest Ophthalmol Vis Sci [Suppl] 30:374","journal-title":"Invest Ophthalmol Vis Sci [Suppl]"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/jop.1989.5.99","volume":"5","author":"A Bar-Ilan","year":"1989","unstructured":"Bar-Ilan A, Pessah NI, Maren TH (1989) Ocular hypotensive activity and disposition of the topical carbonic anhydrase inhibitor 6-hydroxy-benzo[b]thiophene-2-sulfonamide, L-650,719, in the rabbit. J Ocul Pharmacol 5:99?110","journal-title":"J Ocul Pharmacol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/archopht.1974.03900060323017","volume":"91","author":"H Benson","year":"1974","unstructured":"Benson H (1974) Permeability of the cornea to topically applied drugs. Arch Ophthalmol 91:313?327","journal-title":"Arch Ophthalmol"},{"key":"CR5","first-page":"233","volume":"31","author":"H Bourgeois","year":"1990","unstructured":"Bourgeois H, Bron A, Lippa EA, George J-L (1990) 2% L-671,152: multiple-dose activity bid. Invest Ophthalmol Vis Sci (Suppl) 31:233","journal-title":"Invest Ophthalmol Vis Sci (Suppl)"},{"key":"CR6","first-page":"149","volume":"31","author":"WF Brechue","year":"1990","unstructured":"Brechue WF, Maren TH (1990) Factors influencing the intraocular pressure lowering activity of the topical sulfonamide, MK-927. Invest Ophthalmol Vis Sci [Suppl] 31:149","journal-title":"Invest Ophthalmol Vis Sci [Suppl]"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/archopht.1989.01070020209026","volume":"107","author":"AM Bron","year":"1989","unstructured":"Bron AM, Lippa EA, Hofmann HM et al (1989) MK-927: a topically effective carbonic anhydrase inhibitor in patients. Arch Ophthalmol 107:1143?1146","journal-title":"Arch Ophthalmol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/archopht.1991.01080010052031","volume":"109","author":"A Bron","year":"1991","unstructured":"Bron A, Lippa EA, Gunning F, et al (1991) Multiple-dose efficacy comparison of the two topical carbonic anhydrase inhibitors MK-417 and MK-927. Arch Ophthalmol 109:50?53","journal-title":"Arch Ophthalmol"},{"key":"CR9","first-page":"179","volume":"27","author":"L DeSantis","year":"1986","unstructured":"DeSantis L, Sallee V, Barnes G, et al (1986) The effect of topically applied analogs of the carbonic anhydrase inhibitor, ethoxzolamide, on intraocular pressure in alert laser-induced ocular hypertensive cynomolgus monkeys. Invest Ophthalmol Vis Sci 27:179","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"CR10","first-page":"131","volume":"87","author":"M Diestelhorst","year":"1990","unstructured":"Diestelhorst M, Bechetoille A, Lippa EA, et al (1990) Zur Stereospezifitaet der Augendrucksenkung eines lokal applizierten Karboanhydrasehemmers.Fortschr Ophthalmol 87:131?133","journal-title":"Fortschr Ophthalmol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0002-9394(84)90190-9","volume":"98","author":"AJ Flach","year":"1984","unstructured":"Flach AJ, Peterson YS, Seligma KA (1984) Local ocular hypotensive effect of topically applied acetazolamide. Am J Ophthalmol 98:66?72","journal-title":"Am J Ophthalmol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0002-9394(55)91847-X","volume":"40","author":"JS Friedenwald","year":"1955","unstructured":"Friedenwald JS (1955) Current studies on acetazolamide (Diamox) and aqueous humor flow. Am J Ophthalmol 40:139?146","journal-title":"Am J Ophthalmol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/archopht.1985.01050070089036","volume":"103","author":"Z Friedman","year":"1985","unstructured":"Friedman Z, Allen RC, Raph SM (1985) Topical acetazolamide and methazolamide delivered by contact lenses. Arch Ophthalmol 103:963?966","journal-title":"Arch Ophthalmol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0002-9394(79)90561-0","volume":"88","author":"I Goldberg","year":"1979","unstructured":"Goldberg I, Ashburn FS, Kass MA, et al (1979) Efficacy and patient acceptance of pilocarpine gel. Am J Ophthalmol 88:843?846","journal-title":"Am J Ophthalmol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1021\/jm00132a009","volume":"32","author":"SL Graham","year":"1993","unstructured":"Graham SL, Shepard KL, Anderson PS, et al (1993) Topically active carbonic anhydrase inhibitors II. Benzo(b)thiopene sulfonamide derivates with ocular hypotensive activity. J Med Chem 32:2548?2554","journal-title":"J Med Chem"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/02713689008999606","volume":"9","author":"JL Greaves","year":"1990","unstructured":"Greaves JL, Wilson CG, Rozier A, Grove J, Plazonnet B (1990) Scintigraphic assessment of an ophthalmic gelling vehicle in man and rabbit. Curr Eye Res 9:415?420","journal-title":"Curr Eye Res"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/eye.1992.111","volume":"6","author":"FP Gunning","year":"1992","unstructured":"Gunning FP, Bechetoille A, Lippa EA, et al (1992) Sezolamide: additivity to timolol twice daily. Eye 6:525?529","journal-title":"Eye"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archopht.1990.01070030071031","volume":"108","author":"EJ Higginbotham","year":"1990","unstructured":"Higginbotham EJ, Kass MA, Lippa EA, et al (1990) MK-927: a topical carbonic anhydrase inhibitor, dose response and duration of action. Arch Ophthalmol 108:65?68","journal-title":"Arch Ophthalmol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/0002-9394(84)90504-X","volume":"97","author":"DH Johnson","year":"1984","unstructured":"Johnson DH, Epstein DL, Allen RL, et al (1984) A one-year multicenter clinical trial of pilocarpine gel. Am J Ophthalmol 97:723?729","journal-title":"Am J Ophthalmol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0161-6420(88)33109-X","volume":"95","author":"PH Kalina","year":"1988","unstructured":"Kalina PH, Shetlar DJ, Lewis RA, et al (1988) 6-Amino-2-benzothiazolesulfonamide. The effect of a topical carbonic anhydrase inhibitor on aqueous humor formation in the normal human eye. Opthalmology 95:772?777","journal-title":"Opthalmology"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/archopht.1984.01040031479027","volume":"102","author":"RA Lewis","year":"1984","unstructured":"Lewis RA, Schoenwald RD, Eller MG et al (1984) Ethoxzolamide analogue gel. A topical carbonic anhydrase inhibitor. Arch Ophthalmol 102:1821?1824","journal-title":"Arch Ophthalmol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/archopht.1986.01050180076033","volume":"104","author":"RA Lewis","year":"1986","unstructured":"Lewis RA, Schoenwald RD, Bartknecht CF et al (1986) Aminozolamide gel. A trial of a topical carbonic anhydrase inhibitor in ocular hypertension. Arch Ophthalmol 104:842?844","journal-title":"Arch Ophthalmol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1001\/archopht.1988.01060140866029","volume":"106","author":"EA Lippa","year":"1988","unstructured":"Lippa EA, von Denffer HA, Hofmann HM, et al (1988) Local tolerance and activity of MK-927, a novel topical carbonic anhydrase inhibitor. Arch Ophthalmol 106:1694?1696","journal-title":"Arch Ophthalmol"},{"key":"CR24","first-page":"232","volume":"31","author":"EA Lippa","year":"1990","unstructured":"Lippa EA, Sherwood M, Laibovitz RM, et al (1990) MK-417 vs. timolol: comparative activity. Invest Ophthalmol Vis Sci [Suppl] 31:232","journal-title":"Invest Ophthalmol Vis Sci [Suppl]"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0161-6420(91)32295-4","volume":"98","author":"EA Lippa","year":"1991","unstructured":"Lippa EA, Schuman JS, Higginbotham EJ, et al (1991) MK-507 vs. sezolamide: comparative efficacy of two topically active carbonic anhydrase inhibitors. Ophthalmology 98:308?312","journal-title":"Ophthalmology"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/archopht.1991.01080010048030","volume":"109","author":"EA Lippa","year":"1993","unstructured":"Lippa EA, Aasved H, Airaksinen PJ, et al (1993) Multiple-dose dose-response relationship for the topical carbonic anhydrase inhibitor MK-927. Arch Ophthalmol 109:46?49","journal-title":"Arch Ophthalmol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF02133771","volume":"222","author":"VJ Lotti","year":"1984","unstructured":"Lotti VJ, Schmitt CJ, Gautheron PD (1984) Topical ocular hypotensive activity and ocular penetration of dichlorphenamide sodium in rabbits. Graeves Arch Clin Exp Ophthalmol 222:13?19","journal-title":"Graeves Arch Clin Exp Ophthalmol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1001\/archopht.1982.01030040248007","volume":"100","author":"WF March","year":"1982","unstructured":"March WF, Sterwart RM, Mandell AI, et al (1982) Duration of effect of pilocarpine gel. Am J Ophthalmol 100:1270","journal-title":"Am J Ophthalmol"},{"key":"CR29","first-page":"730","volume":"16","author":"TH Maren","year":"1977","unstructured":"Maren TH, Haywood JR, Chapman SK, Zimmerman TJ (1977) The pharmacology of metazolamide in relation to the treatment of glaucoma. Invest Ophthalmol 16:730","journal-title":"Invest Ophthalmol"},{"key":"CR30","doi-asserted-by":"crossref","unstructured":"Maren TH, Jankowska L, Sanyal G et al (1983) The transcorneal permeability of sulfonamide carbonic anhydrase inhibitors and their effect on aqueous humor secretion. Exp Eye Res 457?480","DOI":"10.1016\/0014-4835(83)90041-6"},{"key":"CR31","first-page":"24","volume":"30","author":"SR Michelson","year":"1989","unstructured":"Michelson SR, Schwamm H, Baldwin JJ, et al (1989) Topically instilled MK-927: lack of correlation between corneal penetration rate constant and ocular hypotensive activity in rabbits. Invest Ophthalmol Vis Sci [Suppl] 30:24","journal-title":"Invest Ophthalmol Vis Sci [Suppl]"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bjo.74.7.405","volume":"74","author":"N Pfeiffer","year":"1990","unstructured":"Pfeiffer N, Hennekes R, Lippa EA, et al (1990) A single dose of the topical carbonic anydrase inhibitor MK-927 decreases IOP in patients. Br J Ophthalmol 74:405?408","journal-title":"Br J Ophthalmol"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0378-5173(89)90305-0","volume":"57","author":"A Rozier","year":"1989","unstructured":"Rozier A, Mazuel C, Grove J, Plazonnet B (1989) Gelrite: a novel, ion-activated in-situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol. Int J Pharmaceutics 57:163?168","journal-title":"Int J Pharmaceutics"},{"key":"CR34","first-page":"61","volume":"1","author":"RD Schoenwald","year":"1979","unstructured":"Schoenwald RD, Boltralik JJ (1979) A bioavailability comparison in rabbits of two steroids formulated as high-viscosity gels and reference aqueous preparations. Invest Ophthalmol Vis Sci 1:61?66","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1001\/archopht.1990.01070080080039","volume":"108","author":"JB Serle","year":"1990","unstructured":"Serle JB, Lustgarten JS, Lippa EA, et al (1990) MK-927, A topical carbonic anhydrase inhibitor: dose response and reproducibility. Arch Ophthalmol 108:838?841","journal-title":"Arch Ophthalmol"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0039-6257(84)90168-1","volume":"29","author":"JW Shell","year":"1984","unstructured":"Shell JW (1984) Ophthalmic drug delivery systems. Surv Ophthalmol 29:117?128","journal-title":"Surv Ophthalmol"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0002-9394(83)90017-X","volume":"95","author":"A Stein","year":"1983","unstructured":"Stein A, Pinke R, Krupin T, et al (1983) The effect of topically administered carbonic anhydrase inhibitors on aqueous humor dynamics in rabbits. Am J Ophthalmol 95:222?228","journal-title":"Am J Ophthalmol"},{"key":"CR38","first-page":"534","volume":"232","author":"MF Sugrue","year":"1985","unstructured":"Sugrue MF, Gautheron P, Schmitt C, et al (1985) On the pharmacology of L-645,151: a topically effective ocular hypotensive carbonic anhydrase inhibitor. J Pharmacol Exp Ther 232:534?540","journal-title":"J Pharmacol Exp Ther"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1476-5381.1990.tb14654.x","volume":"99","author":"MF Sugrue","year":"1990","unstructured":"Sugrue MF, Gautheron P, Mallorga P, et al (1990) L-662,583: a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals. Br J Pharmacol 99:59?64","journal-title":"Br J Pharmacol"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3109\/02713689008999600","volume":"9","author":"MF Sugrue","year":"1990","unstructured":"Sugrue MF, Mallorga P, Schwam H, et al (1990) A comparison of L-671,152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animals. Curr Eye Res 9:607?615","journal-title":"Curr Eye Res"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0002-9394(42)91317-5","volume":"25","author":"KC Swan","year":"1942","unstructured":"Swan KC, White NG (1942) Corneal permeability. I. Factors affecting penetration of drugs into the cornea. Am J Ophthalmol 25:1043?1058","journal-title":"Am J Ophthalmol"},{"key":"CR42","first-page":"404","volume":"31","author":"R Vogel","year":"1990","unstructured":"Vogel R, Kulaga SF, Laurence JK, et al (1990) The effect of a Gelrite vehicle on the efficacy of low concentrations of timolol. Invest Ophthalmol Vis Sci [Suppl] 31:404","journal-title":"Invest Ophthalmol Vis Sci [Suppl]"},{"key":"CR43","first-page":"316","volume":"22","author":"EB Werner","year":"1987","unstructured":"Werner EB, Gerber DS, Yolanda JY (1987) Effect of a topical carbonic anhydrase inhibitor, 6-hydroxybenzo[b]-thiophene-2sulfonamide, on intraocular pressure in normotensive subjects. Can J Ophthalmol 22:316?319","journal-title":"Can J Ophthalmol"},{"key":"CR44","first-page":"802","volume":"18","author":"PJ Wistrand","year":"1979","unstructured":"Wistrand PJ, Garg LC (1979) Evidence of a high activity C type of carbonic anhydrase in human ciliary processes. Invest Ophthalmol Vis Sci 18:802","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00919645.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00919645\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00919645","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T16:49:20Z","timestamp":1556556560000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00919645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,7]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1993,7]]}},"alternative-id":["BF00919645"],"URL":"https:\/\/doi.org\/10.1007\/bf00919645","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,7]]}}}